blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1487542

EP1487542 - USE OF ASC-1 INHIBITORS TO TREAT NEUROLOGICAL AND PSYCHIATRIC DISORDERS [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  15.06.2007
Database last updated on 22.01.2025
Most recent event   Tooltip15.06.2007Application deemed to be withdrawnpublished on 18.07.2007  [2007/29]
Applicant(s)For all designated states
H. Lundbeck A/S
Ottiliavej 9
2500 Valby-Copenhagen / DK
[N/P]
Former [2004/52]For all designated states
H. Lundbeck A/S
Ottiliavej 9
2500 Valby-Copenhagen / DK
Inventor(s)01 / THOMSEN, Christian
Kystvejen 321
DK-4671 Stroby / DK
02 / HELBOE, Lone
Roarsvej 17, 4tv
DK-2000 Frederiksberg / DK
03 / EGEBJERG, JENSEN, Jan
Jens Munks Vej 24
DK-8200 Arhus N / DK
 [2004/52]
Representative(s)Kjerrumgaard, Lars Bo, et al
H. Lundbeck A/S, Ottiliavej 9
2500 Valby-Copenhagen / DK
[N/P]
Former [2004/52]Kjerrumgaard, Lars Bo, et al
H. Lundbeck A/S, Ottiliavej 9
2500 Valby-Copenhagen / DK
Application number, filing date03744313.212.03.2003
[2004/52]
WO2003DK00154
Priority number, dateDK2002000041715.03.2002         Original published format: DK 200200417
US20020365070P15.03.2002         Original published format: US 365070 P
[2004/52]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO03077998
Date:25.09.2003
Language:EN
[2003/39]
Type: A1 Application with search report 
No.:EP1487542
Date:22.12.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 25.09.2003 takes the place of the publication of the European patent application.
[2004/52]
Search report(s)International search report - published on:SE25.09.2003
ClassificationIPC:A61P25/08, A61K31/198, A61K31/4172, // C07K14:47
[2004/52]
CPC:
G01N33/502 (EP,US); A61K31/198 (EP,US); A61K31/4172 (EP,US);
A61P25/00 (EP); A61P25/08 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P25/28 (EP); A61P43/00 (EP); C07K14/47 (EP,US);
G01N33/5008 (EP,US); G01N33/5058 (EP,US); G01N33/5076 (EP,US);
G01N33/5088 (EP,US); G01N33/6896 (EP,US); G01N2500/00 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2004/52]
Extension statesAL15.10.2004
LT15.10.2004
LV15.10.2004
MK15.10.2004
TitleGerman:VERWENDUNG VON ASC-1-HEMMERN ZUR BEHANDLUNG VON NEUROLOGISCHEN UND PSYCHIATRISCHEN ERKRANKUNGEN[2004/52]
English:USE OF ASC-1 INHIBITORS TO TREAT NEUROLOGICAL AND PSYCHIATRIC DISORDERS[2004/52]
French:UTILISATION DES INHIBITEURS ASC-1 DANS LE TRAITEMENT DES TROUBLES NEUROLOGIQUES ET PSYCHIATRIQUES[2004/52]
Entry into regional phase15.10.2004National basic fee paid 
15.10.2004Designation fee(s) paid 
15.10.2004Examination fee paid 
Examination procedure01.10.2003Request for preliminary examination filed
International Preliminary Examining Authority: EP
15.10.2004Examination requested  [2004/52]
22.04.2005Despatch of a communication from the examining division (Time limit: M08)
10.04.2006Reply to a communication from the examining division
06.07.2006Despatch of a communication from the examining division (Time limit: M06)
17.01.2007Application deemed to be withdrawn, date of legal effect  [2007/29]
27.02.2007Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2007/29]
Request for further processing for:10.04.2006Request for further processing filed
10.04.2006Full payment received (date of receipt of payment)
Request granted
28.04.2006Decision despatched
Fees paidRenewal fee
31.03.2005Renewal fee patent year 03
31.03.2006Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.03.200705   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO0158944  (JAPAN SCIENCE & TECH CORP [JP], et al);
 [X]WO0108676  (JAVITT DANIEL C [US]);
 [X]US3892852  (JOULLIE MAURICE, et al);
 [X]US4416898  (LE FUR GERARD R [FR]);
 [X]US2002002146  (HALEVIE-GOLDMAN BRIAN D [US]);
 [X]WO9952519  (GEN HOSPITAL CORP [US]);
 [X]US4837219  (HUTTERER JEFFREY [US]);
 [X]EP0387867  (SEARLE & CO [US]);
 [X]  - FUKASAWA Y. ET AL, "Identification and characterization of a Na+-independent neutral amino acid transporter that associates with the 4F2 heavy chain and exhibits substrate selectivity for small neutral D- and L-amino acids", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (20000331), vol. 275, no. 13, pages 9690 - 9698, XP002235447

DOI:   http://dx.doi.org/10.1074/jbc.275.13.9690
 [X]  - NAKAUCHI J. ET AL, "Cloning and characterization of a human brain Na+-independent transporter for small neutral amino acids that transports D-serine with high affinity", NEUROSCIENCE LETTERS, (2000), vol. 287, pages 231 - 235, XP001146487

DOI:   http://dx.doi.org/10.1016/S0304-3940(00)01169-1
 [X]  - MATSUO H. ET AL, "Mouse Asc-1 (asc-type amino acid transporter 1) maps to chromosome 7, region B1-B5", CHROMOSOME RESEARCH, (2000), vol. 8, page 456, XP002968794
 [X]  - THOMSEN C. ET AL, "Characterisation of a D-serine transporter and functional modulation of NMDA receptors", SOCIETY FOR NEUROSCIENCE, (2001), vol. 27, XP002968795
 [X]  - MATSUO H. ET AL, "Cloning, functional characterization and localization of ASC-1; A high affinity amino acid transporter for D-serine", SOCIETY FOR NEUROSCIENCE, (2001), vol. 27, XP002968796
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.